Metastatic non-small cell lung cancer with ALK or ROS-1 positivity, ALK positive anaplastic large cell lymphoma, ALK positive inflammatory myofibroblastic tumor. This evidence concerns the gene ROS1 and inflammatory myofibroblastic tumor.